DataMeds AI and Datavault AI expand healthcare data licensing deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License
July 29, 2026 10:16 AM EDTData monetization and real-world asset tokenization technologies licensed into the DataMeds AI's EinsteinRX Platform
Healthcare data represents 30%+ of global data assets growing by 36% per annum; DVLT and MEDS patented technology platforms designed to value, score and monetize healthcare data
TAMPA, FL / ACCESS Newswire / July 29, 2026 / DataMeds AI, Inc. (NASDAQ: MEDS) ("DataMEDS"), a Health IT company leveraging its artificial intelligence platform EinsteinRx and blockchain-enabled smart contacts platform PharmacyChain to provide integrated solutions for the generation,... More
